Enzo Biochem Q3 EPS $(0.31) Down From $(0.10) YoY, Sales $16.11M Down From $26.22M YoY
Portfolio Pulse from Benzinga Newsdesk
Enzo Biochem reported Q3 losses of $(0.31) per share, a 210% decrease YoY, and sales of $16.11 million, a 38.57% decrease YoY.
June 15, 2023 | 7:40 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Enzo Biochem's Q3 earnings show a significant decrease in both EPS and sales compared to last year.
Enzo Biochem's Q3 earnings report shows a significant decrease in both earnings per share and sales compared to the same period last year. This indicates a negative financial performance, which is likely to have a negative impact on the stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100